menu
    • menu

    Company profile for Avista Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Avista's mission is to develop innovative gene therapies for retinal diseases, including rare, inherited conditions that have a profound impact on patients' quality of life. We leverage our computationally guided scAAVengr platform to generate and validate a toolkit of proprietary AAV vectors that overcome the most significant obstacles to effective gene therapies, including cell-type specific delivery, reduced dosages, and...
    Avista's mission is to develop innovative gene therapies for retinal diseases, including rare, inherited conditions that have a profound impact on patients' quality of life. We leverage our computationally guided scAAVengr platform to generate and validate a toolkit of proprietary AAV vectors that overcome the most significant obstacles to effective gene therapies, including cell-type specific delivery, reduced dosages, and efficient expression, using a minimally invasive intravitreal approach. Our quantitative, in vivo-based approach and clinical ophthalmology expertise allow us to rapidly translate new gene therapies to the clinic.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Avista TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Pittsburgh, PA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.avistatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/avista-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Avista & Forge Announce AAV Develop Manufacturing Partnership
    Avista & Forge Announce AAV Develop Manufacturing Partnership

    13 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250813313772/en/Avista-Therapeutics-and-Forge-Biologics-Announce-AAV-Development-and-cGMP-Manufacturing-Partnership

    BUSINESSWIRE
    13 Aug 2025
    Share Share
    Avista Therapeutics Presents AAV Capsid Data at ARVO 2025 Meeting
    Avista Therapeutics Presents AAV Capsid Data at ARVO 2025 Meeting

    08 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/avista-therapeutics-presents-in-vivo-data-for-its-aav-capsid-in-inherited-retinal-diseases-at-association-for-research-in-vision-and-ophthalmology-2025-annual-meeting-302449244.html

    PR NEWSWIRE
    08 May 2025
    Share Share
    Avista Senior Living Extends Stay by 112 Days with SafelyYou
    Avista Senior Living Extends Stay by 112 Days with SafelyYou

    08 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250408502774/en/Avista-Senior-Living-Increases-Length-of-Stay-by-Incredible-112-Days-with-SafelyYou

    BUSINESSWIRE
    08 Apr 2025
    Share Share
    Avista Announces Effectiveness of Registration Statement
    Avista Announces Effectiveness of Registration Statement

    03 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/avista-public-acquisition-corp-ii-announces-effectiveness-of-registration-statement-and-sets-date-for-extraordinary-general-meeting-to-vote-on-proposed-business-combination-301638828.html

    PRNEWSWIRE
    03 Oct 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search